Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Is SNY A Good Stock To Buy Right Now?’

court, courtroom, gavel, american, flag, legal, desk, background, legally, juror, guilt, chair, table, divorce, judgment, nobody, mallet, tool, brown, decisions, symbol,

Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for Cholesterol Drug Sales

Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen. The article has......(read more)

February 9 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Sanofi SA (ADR) (SNY) Hit With Cease And Desist Order On Dengue Vaccine Ads In The Philippines

The Philippines Food and Drug Administration has ordered Sanofi SA (ADR) (NYSE:SNY) to desist from advertising its dengue vaccine or face major consequences......(read more)

January 4 - News, Stock Analysis - Comments

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over Price Hikes

A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations. The bill seeks to shed......(read more)

January 3 - News, Stock Analysis - Comments

Highest Paid Medical Technicians in America

Regulator Demands Divestiture In Asset Swap Deal Between Boehringer, Sanofi SA (ADR) (SNY)

Boehringer Ingelheim, a German pharmaceutical firm, are involved in plans to divest of five kinds of products for animal health. This is in an effort......(read more)

December 30 - News, Stock Analysis - Comments

Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims

Novo Nordisk A/S (ADR) (NYSE:NVO) has been sued by Sanofi SA (ADR) (NYSE:SNY) for making false claims. In the lawsuit filed in the United States, the......(read more)

December 28 - News, Stock Analysis - Comments

EMA Reviews Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY) Dupixent MAA

The European Medicines Agency (EMA) has recently accepted to review the Marketing Authorization Application (MAA) of Regeneron Pharmaceuticals Inc (NASDAQ......(read more)

December 9 - News, Stock Analysis - Comments

mri, doctor, physicians, display, treatment, idea, medic, experiment, pharmaceutical, patient, future, interface, laboratory, multimedia, intelligence, male, digital, scan,

Sanofi SA (ADR) (SNY) Could Challenge Johnson & Johnson (JNJ) Bid For Actelion Ltd (ALIOF)

Sanofi SA (ADR) (NYSE:SNY) could spark a fierce bidding war for Actelion Ltd (OTCMKTS:ALIOF). Johnson & Johnson (NYSE:JNJ) has already entered talks......(read more)

December 6 - News, Stock Analysis - Comments

Sanofi SA (ADR) (SNY) Facing Manufacturing Headache On Two Blockbusters

Manufacturing problems in France threaten to delay the release of Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN)’s blockbuster......(read more)

November 30 - News, Stock Analysis - Comments

people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6

The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE......(read more)

November 23 - News, Stock Analysis - Comments

Sanofi SA (ADR) (SNY) Can Thank Its Vaccines

Sanofi SA (ADR) (NYSE:SNY) Pasteur seems to be making it big with its vaccines. In the third quarter the French drugmaker’s sales grew by 14% over last......(read more)

November 3 - News, Stock Analysis - Comments

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasn’t

Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory......(read more)

September 6 - News, Stock Analysis - Comments

FDA’s Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi

We just learnt that the FDA has pushed back its decision day on Sanofi SA (ADR) (NYSE:SNY)’s insulin combo candidate IGlarLixi. Markets haven’t moved......(read more)

August 22 - News, Stock Analysis - Comments

Will Pluristem Therapeutics Inc. (PSTI) Succeed in CLI Where Sanofi SA (ADR) (SNY) Failed?

It’s every junior biotech company’s dream to be accepted into an accelerated approval pathway for a potentially blockbuster drug. Very few achieve......(read more)

August 11 - News, Stock Analysis - Comments

Healthcare Careers That Require a Master’s Degree

As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs

In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies......(read more)

June 27 - News, Stock Analysis - Comments

medicine, diabetes, glycemia, health care,patient, insulin-deficient, middle, app, measurement, male, disease, hypoglycemia, level, technology, medicine, mobile, checking, body, home, smartphone, hyperglycemia, stripe, part, health, indoors, man, glucometer, healthcare, test, human, diabetic, aged, medical, unhealthy, concept, gadget, ill, diabetes, sick, glucose, care, problem, person, cell, sugar, control, application, phone, blood, hand, insulin

The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All

At the turn of the millennium, the population of the United States clocked in at 282.2 million. By 2030, the US population is expected to be about 362......(read more)

June 22 - News, Stock Analysis - Comments

GlaxoSmithKline PLC (ADR) (GSK) Poised To Overtake Sanofi SA (ADR) (SNY) In This $1.8 Billion Market

GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales......(read more)

June 8 - News, Stock Analysis - Comments